Navigation Links
Anastrozole in Medical News

Genomic Health Announces Study Establishing the Utility of Oncotype DX(R) in Node-Negative and Node-Positive Breast Cancer Patients Treated with Aromatase Inhibitors

...ients who are treated with the aromatase inhibitor anastrozole or with tamoxifen. Researchers from the Royal Ma...ly stage breast cancer patients planned for either anastrozole or tamoxifen treatment." The study assesse...itive (p=0.003) patients. The greater efficacy of anastrozole observed in the parent ATAC trial and the similar ...

Patient management: Quality of life and beyond

...urvival Abstract #1136, Shozo Ohsumi, M.D., Ph.D. Embargo: 5:30 p.m. CST, December 11, 2008 After one to four years of tamoxifen, switching to anastrozole improves disease-free survival by about 31 percent, but patients pay a price in quality of life measures. The difference in quality of life is signifi...

Hot Flashes, Night Sweats a Good Sign for Breast Cancer Patients

...mptoms at their first follow-up visit during a trial assessing tamoxifen or anastrozole for adjuvant therapy of postmenopausal breast cancer. The 37.5 percent o...anastrozole. Overall, patients with and without these symptoms who received anastrozole had lower recurrence rates than those who received tamoxifen. The study ...

Breast Cancer Drug Not Tied to Cognitive Decline: Study

...ing is 'good news' for postmenopausal women taking anastrozole TUESDAY, Sept. 2 (HealthDay News) -- C...previous study results, the cancer prevention drug anastrozole does not appear to cause impairment of cognitive performance, a new study found. anastrozole has been shown to be superior to tamoxifen in prev...

Hormone Drug Type Makes Survival Difference in Advanced Breast Cancer

...trogen stimulates tumor growth. Aromatase inhibitors work by limiting a woman’s production of estrogen. Several aromatase inhibitors, including anastrozole (Arimidex), exemestane (Aromasin) and letrozole (Femara) have been available for clinical use for the past decade or so. Other breast cancer tre...

Breast Cancer may no longer be a killer disease

...er Campaign, said, "Women now had a much better chance of surviving breast cancer. "As well as drugs like Herceptin and aromatase inhibitors such as anastrozole and letrozole, patients can also benefit from better cosmetic results which can have a significant psychological impact. "While a cure for everyon...

Arimidex-Herceptin Combo Therapy For Breast Cancer-Clinical Trial Findings

...statistically significant since patients on Arimidex alone have their survival prolonged to 23.9 months. Additional data showed that introducing anastrozole instead of Tamoxifen in early hormone sensitive breast cancer among postmenopausal women increased their chances of avoiding disease recurrence. S...

Aromatase Inhibitors Better Than Tamoxifen For Treating Receptor-Positive Early Breast Cancer

... Researchers have found that aromatase inhibitors like anastrozole are more effective in treating postmenopausal women with hormone receptor-p...n with early breast cancer for more than 5 years and found that patients on anastrozole had much less adverse effects and the drug was well tolerated by patients. ...

More Breast cancer Cases Diagnosed In The UK

...the recurrence of the disease. The benefits derived from both tamoxifen and anastrozole are being studied. The DCIS is considered a pre-cancerous condition, which ...not taking drugs which are capable of preventing the cancer from returning. anastrozole is reported to be more effective than tamoxifen when it comes to reducing t...

Anastrozole Is A More Effective Cancer Drug

...e deaths among the 2,009 women who changed over to anastrozole was 66, while in the case of tamoxifen, it was 90. AstraZeneca is marketing anastrozole as Arimidex, and this has received the support of ...urrence of breast cancer by 50%, and administering anastrozole reduces it by a further 26%. In the UK alone...
Anastrozole in Medical Technology

Video: Zometa(R) Reduces Risk of Breast Cancer Recurrence in Premenopausal Women, Study in The New England Journal of Medicine Reports

...arian suppression, and randomly assigned into one of four study groups: (1) anastrozole plus Zometa; (2) anastrozole alone; (3) tamoxifen plus Zometa; (4) tamoxifen alone. The treatment period...

Three Clinical Studies of bioTheranostics Molecular Breast Cancer Diagnostics Presented at San Antonio Breast Cancer Symposium

...ancer Index in women with breast cancer randomized to receive five years of treatment with tamoxifen or two years of tamoxifen followed by three years anastrozole treatment. The researchers found that the Theros Breast Cancer Index will identify, among patients with early stage breast cancer, those with a higher...

Meditrina Pharmaceuticals, Inc. Opens Investigational New Drug (IND) Application for Phase IIb Clinical Trial With MPI-676 in Endometriosis

...lower than for which AstraZeneca has already established two-year chronic use safety data in their breast cancer prevention trials and is cited in the anastrozole product label. These data will advance development of MPI-676 and help us bring this important new treatment to women suffering from endometriosis, a ...

Video: Major Independent Trial Demonstrates Significant Anticancer Benefit of Zometa(R) in Women With Early-Stage Breast Cancer

...arian suppression, and randomly assigned into one of four study groups: (1) anastrozole plus Zometa; (2) anastrozole alone; (3) tamoxifen plus Zometa; (4) tamoxifen alone. The treatment period...

Video: New Results From One of the World's Largest Breast Cancer Trials Herald Hope for Thousands of Women

...sal women with early breast cancer, reinforce that anastrozole can help many more women live cancer-free, for longer. For the first time, anastrozole has been shown to be the only treatment of its typ...a woman's treatment ends, the protective effect of anastrozole in reducing the risk of hormone-sensitive early br...

Anastrozole Confirmed Superior in Breast Cancer Prevention

... SAN ANTONIO, Dec. 14 /PRNewswire/ -- anastrozole is more effective than tamoxifen at preventing bre... tamoxifen with 5 years of the aromatase inhibitor anastrozole for the treatment of postmenopausal women with inv...e completion of treatment), patients who had taken anastrozole continued to show reduced rates of tumor recurrenc...

Anastrozole (Arimidex) Improves Overall Survival in Postmenopausal Women with Early Breast Cancer Receiving Treatment with Tamoxifen

...nificantly improved by switching from tamoxifen to anastrozole (Arimidex). An analysis of the 'Arimidex'-'Nolvade...I). The study demonstrated that women switching to anastrozole (n=489) rather than remaining on tamoxifen (n= 490...opportunity to receive an aromatase inhibitor like anastrozole immediately after surgery and chemotherapy to prov...

First single breast cancer study to show significant survival benefit for women switching from tamoxifen to Arimidex

... anastrozole (ArimidexTM) improves overall survival in postmeno...nificantly improved by switching from tamoxifen to anastrozole (ArimidexTM). An analysis of the ‘Arimidex&r...I). The study demonstrated that women switching to anastrozole (n=489) rather than remaining on tamoxifen (n= 490...
Anastrozole in Biological News

Mayo Clinic research on tamoxifen leads to recommendation for CYP2D6 gene test

...followed by three years of anastrozole, an aromatase inhibitor. The initial results of ABCSG-8, reported in 2005, concluded that women who switched to anastrozole had a 40 percent reduced risk of breast cancer recurrence compared to staying on tamoxifen. The aim of the new study was to determine whether CYP...

New research shows no link between aromatase inhibitors and cardiovascular problems

...his was important and reassuring news for women. AIs, such as letrozole, anastrozole and exemestane, work by causing severe oestrogen deprivation and, increasin...ascular events in comparison to tamoxifen is not significant for letrozole, anastrozole or exemestane. Furthermore, the frequency of fatal heart attacks in the ...
Anastrozole in Biological Technology

Genomic Health to Present Multiple New Studies at 31st Annual San Antonio Breast Cancer Symposium

...ntation (General Session 5): "Risk of distant recurrence using Oncotype DX in postmenopausal primary breast cancer patients treated with anastrozole or tamoxifen: a TransATAC study" Presenter: Mitch Dowsett, Ph.D., Royal Marsden Hospital, London Location: Exhibit Hall D Abou...

Genomic Health Announces Third Quarter 2008 Financial Results and Business Progress

...pe DX in postmenopausal primary breast cancer patients treated with anastrozole or tamoxifen: a TransATAC study" -- "GRB7-dependent pathways a...edict response to neoadjuvant endocrine therapy including tamoxifen and anastrozole at the ASCO Breast Cancer Symposium in September. Conference Call Det...

Meditrina Pharmaceuticals, Inc. Announces Exclusive Global License Agreement With AstraZeneca

...ct profile and duration of treatment. "I am pleased that Meditrina will be pursing this indication, leveraging the work done to date by AstraZeneca. anastrozole in combination with an estrogen and progestin in the area of women's gynecologic indications represents a valid medical approach and sits well with Me...
Other Tags
(Date:8/20/2014)... “Have you recently been involved in an auto ... lawyer serving the greater Seattle area. “Are you still feeling ... keep reading . , In a recently released article, Dax ... accident can use to see if they may qualify for ... insurance claim will allow an individual to receive medical treatment ...
(Date:8/20/2014)... Springs, California (PRWEB) August 20, 2014 ... , designed the innovative RevitaDERM® Psoriasis Treatment ... that is associated with psoriasis. This all-in-one product ... symptoms. , RevitaDERM® Psoriasis Treatment is powered by ... odor commonly associated with this effective ingredient. ...
(Date:8/20/2014)... they often have difficulty falling asleep and staying asleep, ... In individuals with Alzheimer,s disease, this common and troubling ... leading to nighttime confusion and wandering. , Now, a ... Center (BIDMC) and the University of Toronto/Sunnybrook Health Sciences ... age. Reported online today in the journal Brain ...
(Date:8/20/2014)... GBK, the luxury lifestyle gift lounge and special events ... at the annual GBK Gift Lounge. This year’s event will ... from 11am – 6pm. GBK will offer guests an opportunity ... , As always, GBK will blend this award show celebration ... lounge. GO Campaign is a grantmaking organization that improves the ...
(Date:8/20/2014)... Kowa Optimed returns after a short ... the new SL-17 portable slit lamp. , The SL-17 ... source controlled by an illuminated thumb wheel for easy ... commercially available AAA rechargeable and dry cell batteries, which ... batteries designed specifically for the device. The new Sl-17 ...
Breaking Medicine News(10 mins):Health News:Five Questions to Determine Who Qualifies for a Personal Injury Claim Recently Released by The Jones Firm in Recent Article 2Health News:RevitaDERM® Psoriasis Treatment Now Available At Over 7,600 CVS/pharmacies 2Health News:Research helps explain why elderly have trouble sleeping 2Health News:Research helps explain why elderly have trouble sleeping 3Health News:GBK Presents a Luxury Gift Lounge Honoring the Nominees and Presenters of the 2014 Emmy® Awards - August 22nd and 23rd - Beverly Hills 2Health News:GBK Presents a Luxury Gift Lounge Honoring the Nominees and Presenters of the 2014 Emmy® Awards - August 22nd and 23rd - Beverly Hills 3Health News:GBK Presents a Luxury Gift Lounge Honoring the Nominees and Presenters of the 2014 Emmy® Awards - August 22nd and 23rd - Beverly Hills 4Health News:Kowa Optimed (Booth MS13043) to Debut New Portable Slit Lamp at 2014 Vision Expo West in Las Vegas, Nevada 2
(Date:8/19/2014)... devised a new implantable tissue scaffold coated with bone ... weeks. When applied to bone injuries or defects, this ... bone that looks and behaves just like the original ... a dramatic improvement over the current standard for treating ... of the patient,s body a painful process that ...
(Date:8/19/2014)... infants born with neonatal abstinence syndrome (NAS) secondary ... time going through withdrawal than others, but the ... and epigenetic (when genes are turned on or ... factors, researchers at Boston University School of Medicine ... first of its kind study to identify some ...
(Date:8/19/2014)... The ancestors of today,s crocodiles colonised the seas during ... to a new Anglo-French study which establishes a link ... temperature over a period of more than 140 million ... Martin from the Universit de Lyon, France and formerly ... week in Nature Communications ., Today, crocodiles are ...
Breaking Biology News(10 mins):Engineering new bone growth 2Engineering new bone growth 3In-utero methadone, Subutex exposure could alter gene expression, cause severe Neonatal Abstience Syndrome 2Evolution of marine crocodilians constrained by ocean temperatures 2
Other Contents